CPT® Code 83661

A fetal lung maturity assessment is a critical test conducted to evaluate the development of a fetus's lungs prior to delivery. This assessment specifically utilizes the lecithin sphingomyelin (L/S) ratio, which is derived from an analysis of amniotic fluid. The primary purpose of this test is to assess lung maturity and to estimate the likelihood of the newborn developing respiratory distress syndrome (RDS), also known as hyaline membrane disease, after birth. The L/S ratio provides valuable information that can influence clinical decisions regarding the management of premature labor. If the test indicates that the fetal lungs are not yet mature, healthcare providers may consider interventions to suppress premature labor. Conversely, if the lungs are deemed mature enough, it may be appropriate to allow labor to progress or to induce labor in cases where the mother's or fetus's health is compromised. The assessment involves obtaining a sample of amniotic fluid, which is then analyzed to determine the L/S ratio. Lecithin, a component of pulmonary surfactant, increases in concentration as the fetus's lungs mature, while sphingomyelin, a non-pulmonary lipid, remains relatively stable in the amniotic fluid. The resulting L/S ratio is expressed numerically, with ratios greater than 2 indicating a lower risk of RDS, thereby guiding clinical decisions regarding delivery and neonatal care.